This week, we’re continuing our coverage of results presented at the 2021 Genitourinary Cancers Symposium, focusing on research findings in renal cell carcinoma and bladder cancer.To listen to more podcasts from ASCO, visit <a href="https://www.asco.org/about-asco/asco-digital/podcasts">asco.org/podcasts</a>.

This week, we’re continuing our coverage of results presented at the 2021 Genitourinary Cancers Symposium, focusing on research findings in renal cell carcinoma and bladder cancer. To listen to more podcasts from ASCO, visit asco.org/podcasts.

This week, we’re continuing our coverage of results presented at the 2021 Genitourinary Cancers Symposium, focusing on research findings in renal cell carcinoma and bladder cancer.To listen to more podcasts from ASCO, visit <a href="https://www.asco.org/about-asco/asco-digital/podcasts" rel="noopener noreferrer">asco.org/podcasts</a>.

Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer

News and views from the world of clinical oncology and hematology.

Share Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer

Sign up to save your podcasts

Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer

Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer

More shows like The ASCO Post Podcast

Research To Practice | Oncology Videos

ASCO Daily News